Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 120INDUSTRY 6NETWORK 2OTHER_GOV 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1

Conditions

Breast Neoplasms 2Recurrence 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Blood Specimen Collection × Breast × Clear all
NCT07084558 2025-10-28

TEODOR

Austrian Breast & Colorectal Cancer Study Group

Phase NA Recruiting
350 enrolled
Breast

Breast Neoplasms

NCT04995575 2024-02-22

MINDACTRelapse

European Organisation for Research and Treatment of Cancer - EORTC

Terminated
31 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡